Candriam Equities L Biotechnology C - Thesaurierung/ LU0108459040 /
NAV2024-05-13 | Chg.+5.8800 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
826.0500USD | +0.72% | reinvestment | Equity Worldwide | Candriam ▶ |
GlobeNewswire
2:15 PM
Gratus Capital Partners with iCapital® to Launch Hedge Fund Investing Opportunities to Wealth Manage...
GlobeNewswire
12:55 PM
YieldMax™ ETFs Announces Monthly Distributions on Fund of Funds and Ultra ETFs
GlobeNewswire
12:15 AM
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of April 2024